Sera Prognostics (SERA) Income from Continuing Operations (2020 - 2026)
Sera Prognostics' (SERA) quarterly Income from Continuing Operations came in at 10858000.0 in Q1 2026, down 27.82% YoY from 15042190.15 in Q1 2025, and down 110.34% on a QoQ basis from 5162000.0 in Q4 2025.
Sera Prognostics (SERA) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Income from Continuing Operations data on file, last reported at 10858000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 27.82% year-over-year to 10858000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 41054000.0 (down 19.74% YoY) and the FY2025 annual result came in at 117951000.0, down 5.32% from the prior year.
- Income from Continuing Operations slipped to 10858000.0 in Q1 2026, from 5162000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 5162000.0 in Q4 2025 to a low of 12653000.0 in Q3 2025.
- A 5-year average of 9931235.29 and a median of 10436000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 70.51% — and 2025, when it jumped 41.05%.
- Tracing SERA's Income from Continuing Operations over 5 years: stood at 10436000.0 in 2022, then rose by 23.99% to 7932000.0 in 2023, then slipped by 10.39% to 8756000.0 in 2024, then jumped by 41.05% to 5162000.0 in 2025, then plunged by 110.34% to 10858000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 10858000.0 (Q1 2026), 5162000.0 (Q4 2025), and 12653000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Sera Prognostics | 104.49 Mn | 104.49 Mn | -20,000.00 | -9.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.23 Mn |
| Mar 31, 2026 | -10.86 Mn |
| Dec 31, 2025 | -5.16 Mn |
| Sep 30, 2025 | -12.65 Mn |
| Jun 30, 2025 | -12.38 Mn |
| Mar 31, 2025 | -8.50 Mn |
| Dec 31, 2024 | -8.76 Mn |
| Sep 30, 2024 | -8.29 Mn |
| Jun 30, 2024 | -8.74 Mn |
| Mar 31, 2024 | -8.92 Mn |
| Dec 31, 2023 | -7.93 Mn |
| Sep 30, 2023 | -7.83 Mn |
| Jun 30, 2023 | -11.47 Mn |
| Mar 31, 2023 | -11.35 Mn |
| Dec 31, 2022 | -10.44 Mn |
| Sep 30, 2022 | -11.21 Mn |
| Jun 30, 2022 | -11.90 Mn |
| Mar 31, 2022 | -12.45 Mn |
| Dec 31, 2021 | -12.02 Mn |
| Sep 30, 2021 | -9.88 Mn |